SCHEMBL1274880

SCHEMBL1274880

[N]C1CCC=CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18199914 0.67
SCHEMBL3626952 0.67
SCHEMBL14360974 0.67
SCHEMBL6243003 0.67
SCHEMBL1162653 0.67
SCHEMBL12569212 0.63
SCHEMBL16794757 0.62
SCHEMBL10766052 0.62
SCHEMBL11007419 0.62
SCHEMBL4022348 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120172392-A1 AMINE-BASED AND AMIDE-BASED INHIBITORS OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) ENZYME ACTIVITY AND VAP-1 MEDIATED ADHESION USEFUL FOR TREATMENT OF DISEASES SALTER-CID LUISA M (US) 2012-07-05 US disclosed
EP-2283833-A2 Amines and amides for the treatment of diseases LA JOLLA PHARMACEUTICAL CO. (US) 2011-02-16 EP disclosed
US-20070078157-A1 Amine-based and amide-based inhibitors of semicarbazide-sensitive amine oxidase (SSAO)enzyme activity and VAP-1 mediated adhesion useful for treatment of diseases LA JOLLA PHARMACEUTICAL COMPANY (US) 2007-04-05 US disclosed
EP-1732531-A2 AMINES AND AMIDES FOR THE TREATMENT OF DISEASES LA JOLLA PHARMACEUTICAL COMPANY (US) 2006-12-20 EP disclosed
US-20060025438-A1 Amine-based and amide-based inhibitors of semicarbazide-sensitive amine oxidase (SSAO) enzyne activity and VAP-1 mediated adhesion useful for treatment of diseases LA JOLLA PHARMACEUTICAL COMPANY 2006-02-02 US disclosed
WO-2005082343-A2 AMINES AND AMIDES FOR THE TREATMENT OF DISEASES LA JOLLA PHARMACEUTICAL COMPANY (US) 2005-09-09 WO disclosed